Xia, Yanjie
Yu, Feng
Bai, Ying
Jiang, Lili
Shi, Panlai
Jiang, Zhengwen
Kong, Xiangdong https://orcid.org/0000-0003-4322-914X
Funding for this research was provided by:
the National Key R&D Program of China (2018YFC1002206)
Natural Science Foundation of Henan Province (222300420338)
Article History
Received: 1 February 2024
Accepted: 13 October 2024
First Online: 28 October 2024
Ethics approval and consent to participate
: The protocol and informed consent (Ethics number: 2018-YB-08) were approved by the Research and Clinical Trials Ethics Committee of the First Affiliated Hospital of Zhengzhou University. All research participants or their legal representatives signed informed consent forms for participation in clinical and genetic research. All methods were performed in accordance with the relevant guidelines and regulations in accordance with the Declaration of Helsinki in this study.
: The authors affirm that human research participants provided informed consent for publication.
: The authors declare no conflict of interest.